Friday, Aug 21, 2026

"dot1l-enzyme"

Potential therapeutic target identified for ovarian cancer

Others have found that DOT1L is overexpressed in several cancer types, and recent clinical work has shown synergistic ant proliferative activity for a DOT1L inhibitor against MLL-rearranged leukaemia.

Latest News

NTA defends Rs 200 answer key challenge fee, says it benefits all candidates

3 hours ago
Magnitude 6.7 earthquake strikes southern Peru; no damage reported

3 hours ago
Iran accuses US of ‘economic war’ as Trump threatens tougher sanctions

3 hours ago
Opinion: Section 22-A and Right to Property

4 hours ago
Houthis claim drone attacks on Saudi airport, Aramco facility

4 hours ago
Editorial: Trump’s tariff tantrums fail to dent India’s exports

5 hours ago
India U-20 held to 0-0 draw by Yemen in friendly

4 hours ago
East Bengal women smash 12-0 record win in AFC Women’s Champions League

5 hours ago